Drug and pharma manufacturing with process analytical technology

Optimized process understanding

Drug Production (PAT)

Today's competitive industrial environment requires drug manufacturing that continuously strives to improve product quality while reducing production costs.

Bruker is committed to the development and support of leading-edge technology for FT-IR,FT-NIR and Raman spectroscopy systems for both the laboratory and the process environment. The FDA Process Analytical Technology (PAT) initiative is an effort to facilitate the introduction of new technologies to the manufacturing sectors of the pharmaceutical industry. 

PAT systems provide timely analysis of critical quality parameters aiming at the improvement of final product quality as well as reducing pharma manufacturing costs, thereby significantly supporting the public health sector as well as the pharmaceutical industry.